A descriptive analysis of concomitant opioid and benzodiazepine medication use and associated adverse drug events in United States adults between 2009 and 2018
Background: In 2016, the Centers for Disease Control and Prevention (CDC) published guidelines for prescribing opioids for chronic pain in response to the opioid epidemic and recommended avoiding concomitant use of opioid and benzodiazepine medications whenever possible. However, based on a recent r...
Saved in:
Main Authors: | Kathryn K. Marwitz (Author), Marwa Noureldin (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Variation in adverse drug events of opioids in the United States
by: Edward Y. Liu, et al.
Published: (2023) -
Analyses of non-benzodiazepine-induced adverse events and prognosis in elderly patients based on the Japanese adverse drug event report database
by: Yoshihiro Noguchi, et al.
Published: (2018) -
Opioid and benzodiazepine dispensing and co-dispensing patterns among commercially insured pregnant women in the United States, 2007-2015
by: Danya M. Qato, et al.
Published: (2021) -
Adverse outcomes associated with concurrent gabapentin, opioid, and benzodiazepine utilization: A nested case-control study
by: Abisola Olopoenia, et al.
Published: (2022) -
Pharmacist-Led Deprescribing of Opioids and Benzodiazepines in Older Adults: Examining Implementation and Perceptions
by: Tamera D. Hughes, et al.
Published: (2024)